2026-04-07T01:37:34Z https://pub.unibl.org/oai

oai:pub.unibl.org:38777 2025-12-10T04:43:23Z

Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir± Ribavirin in Treatment of Patients With Chronic Hepatitis C in the Republic of Srpska: a Real-Life Study /unibl/sci/idNaucniRad:24182 616.36-002(497.6RS) https://dx.doi.org/10.5937/scriptamed50-22255 Academic Article text 2019-02 A. Verhaz, Z. Kezić, R. Škrbić, M. Stoiljković, Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir± Ribavirin in Treatment of Patients With Chronic Hepatitis C in the Republic of Srpska: a Real-Life Study, STED Journal, Vol. 50, No. 3, pp. 77 - 81, Feb, 2019 77 81 STED Journal 2637-2150 https://www.unibl.org/sr-lat/fis/zaposlen/3299-antonija-verhaz /unibl/author/Zdravka Kezić /unibl/author/Ranko Škrbić /unibl/author/Miloš Stoiljković https://med.unibl.org STED Journal 2637-2150 81 77 https://www.unibl.org/sr-lat/fis/zaposlen/3299-antonija-verhaz /unibl/author/Zdravka Kezić /unibl/author/Ranko Škrbić /unibl/author/Miloš Stoiljković https://pub.unibl.org/s/cir/item/38777